Talk About a Revolution: From Acting Up to Acts of Congress, AIDS Activist Reviews and Critiques a Decade of Social Change
TAGline • 1998From Acting Up to Acts of Congress, AIDS Activist Reviews and Critiques a Decade of Social Change Green light, red light at FDA At last month’s 4th International Congress on Drug Therapy in HIV Infection (Glasgow, Scotland, U.K.), TAG’s Mark Harrington was invited to speak at the opening ceremony which convened Sunday evening at the…
Swift Success: CDC/Thai Vertical Transmission Results Silence Critics and Pave Way for Prevention of Millions of Infections Worldwide
TAGline • 1998CDC/Thai Vertical Transmission Results Silence Critics and Pave Way for Prevention of Millions of Infections Worldwide But who will bear the cost? Four years ago, results of ACTG 076 showed that HIV-infected pregnant women treated with a complex regimen of AZT (100 mg five times daily during the third trimester of pregnancy, intravenous AZT (1…
AIDS Related Opportunistic Infections Report, 1998
Publication • 1998AIDS Related Opportunistic Infections Report (Version 2.0) By Michael Marco, Steve Kass, Paul Dietz, Laura Morrison, Theo Smart, Evan Wilder, Tim Horn and Mark Harrington February 1998 From the Introduction Six years ago, at the Amsterdam AIDS Conference, I joined a group of activists to zap the Astra booth in protest at the obscene price…
START Stopped: Nearly Everyone Agrees On the Need for ‘Strategy’ Type Clinical Studies — And That’s Where Consensus Ends
TAGline • 1997Nearly Everyone Agrees On the Need for ‘Strategy’ Type Clinical Studies — And That’s Where Consensus Ends An intrepid Dr. Lange scales Mt. Sinai First there was the CPCRA’s “Moving Target” protocol, which entailed half a decade of arduous, dog-chasing-its-tail conference calls and draft after draft after endless draft of protocol revisions, each one more…
Scammed: Roche Racks Up Millions In Early Saquinavir Sales While Unwitting Patients Prime Themselves for Protease X-Resistance
TAGline • 1997Roche Racks Up Millions In Early Saquinavir Sales While Unwitting Patients Prime Themselves for Protease X-Resistance Community cries for compensation Cynical, greedy, manipulative, opportunistic, penny-pinching, short-sighted, slipshod. Do these words come to mind when you think of Hoffmann-La Roche’s AIDS drug development effort? They should. Examples of such behavior are legion, from the fiasco that…
Azithro v. Clarithro: Two Drugs Might Be Better Than One for Prophylaxis of M. Avium Disease, But Are Any of Them Clarithromycin?
TAGline • 1996Two Drugs Might Be Better Than One for Prophylaxis of M. Avium Disease, But Are Any of Them Clarithromycin? 24-29% with resistant bugs There was a good amount of new data released early last month at the Third Conference on Retroviruses and Opportunistic Infections in Washington, D.C. While it was unlikely that any OI news…
Viral Load Comes of Age: Propelled by Results From Multiple Studies, Viral Load Monitoring Lunges to the Forefront of HIV Medicine
TAGline • 1996Something to Measure Propelled by Results From Multiple Studies, Viral Load Monitoring Lunges to the Forefront of HIV Medicine Optimization — and Access — Remain Recently, several very powerful and sensitive tests for measuring the presence of HIV RNA in the blood have become available to clinicians and patients (although primarily to those with insurance…
CPCRA v. Syntex: Effect of ddI on Ganciclovir May Explain Disparity Between Two Prophylaxis Studies
TAGline • 1996Effect of ddI on Ganciclovir May Explain Disparity Between Two Prophylaxis Studies And CMV PCR Makes its Debut Readers of TAGline are asked to harken back to the duelling ganciclovir studies unveiled this past winter (see the March TAGline, vol. 3, issue 2). Where the Syntex study #1654 (now Syntex/Roche) declared a huge benefit to…
Deconstructing the Drama: Former ACT UP/NY Scientific Wunderkind Denounces Movement As “Messianic Utopianism”
TAGline • 1996Former ACT UP/NY Scientific Wunderkind Denounces Movement As “Messianic Utopianism” AIDS Activism as Religious Cult At a recent conference entitled “Acting on AIDS” at the Institute for Contemporary Art in London, TAG’s Mark Harrington was invited to deliver the keynote address. His remarks, “From Therapeutic Utopianism to Pragmatic Praxis: Some Transitions in the History of…
Retroviral Reprise: Confab’s Clarion Call: “Get It Down and Keep It Down,” with Hints–And Only Hints–Of How To Get There
TAGline • 1996Confab’s Clarion Call: “Get It Down and Keep It Down,” with Hints–And Only Hints–Of How To Get There Heyday for RNA At long last, the data nearly justifies the hype! Activists, doctors and researchers were almost giddy with excitement following the 3rd Conference on Retroviruses and Opportunistic Infections in Washington, D.C. Data on new anti-HIV…